Monness Crespi Hardt

Monness Crespi Hardt upgraded TripAdvisor (NASDAQ: TRIP) from Neutral to Buy and announced a $60.00 price target. Monness Crespi Hardt noted, "We are upgrading TRIP to Buy because we think 2013 expectations, which will surely follow management's conservative guidance, will likely be too low. We...

In a report published Monday, Monness Crespi Hardt reiterated its Buy rating on Lindsay Corporation (NYSE: LNN), and raised its price target from $95.00 to $100.00. Monness Crespi Hardt noted, “We recently held meetings with LNN management and came away with greater confidence in both the current...

Monness Crespi Hardt downgraded W.R. Grace (NYSE: GRA) from Buy to Neutral and raised the price target from $67.00 to $79.00. Monness Crespi Hardt noted, "We are downgrading GRA to Neutral as we see limited near term upside after the shares' significant appreciation over the past 12-months (30...

In a report published Monday, Monness Crespi Hardt downgraded its rating on Tiffany & Co. (NYSE: TIF) from Buy to Neutral. Monness Crespi Hardt noted, “At current levels the stock sells at 18.5x the January 2014 estimate of $3.50/share. The 2014 estimate assumes a 9% growth rate in earnings...

In a report published Monday, Monness Crespi Hardt downgraded its rating on Expedia (NASDAQ: EXPE) from Buy to Neutral, and reiterated its $70.00 price target. Monness Crespi Hardt noted, “We are downgrading EXPE shares to Neutral from Buy. We are downgrading EXPE shares because they are modestly...

Monness Crespi Hardt reiterated its Buy rating on Apple (NASDAQ: AAPL) and lowered the price target from $750.00 to $670.00. Monness Crespi Hardt noted, "Supply chain checks leave us comfortable with 47 mln iPhones in 1QFY13, but suggest less than 40 mln builds for 2QFY13. Display constraints...

Monness Crespi Hardt downgraded Shutterfly (NASDAQ: SFLY) from Buy to Neutral. Monness Crespi Hardt commented, "We are downgrading SFLY shares because: 1) Shares have appreciated by 32% since our February 2nd, 2012 upgrade in part because the company has consistently exceeded low revenue and...

Monness Crespi Hardt downgraded Dell (NASDAQ: DELL) from Buy to Neutral and removed its $13 price target. Monness Crespi Hardt noted, "Bloomberg reported that Dell is in discussions with at least two private equity shops regarding a potential LBO. … The sheer size of the LBO may prove prohibitive...

In a report published Monday, Monness Crespi Hardt initiated coverage on LeapFrog Enterprises (NYSE: LF) with a Buy rating and $12.00 price target. Monness Crespi Hardt noted, “As the leader in the learning toys category, we believe LeapFrog has a strong competitive position. In 2011, LeapFrog had...

In a report published Friday, Monness Crespi Hardt downgraded its rating on Finish Line (NASDAQ: FINL) from Buy to Neutral, and removed its price target. Monness Crespi noted, “We are downgrading FINL shares to Neutral (from Buy) and suspending our price target. The running footwear cycle has...

Monness Crespi Hardt reduced its rating on Ferro Corporation (NYSE: FOE) from Buy to Neutral with a $4 price target. Monness Crespi Hardt noted, "We are downgrading Ferro from Buy to Neutral as its shares now exceed our $4 price target. The recent run in FOE shares has seen them climb over 70%...

Monness Crespi Hardt reiterated its Buy rating on Rockwood Holdings (NYSE: ROC) but lowered its price target from $59 to $54. Monness Crespi Hardt said, "We are lowering our 4Q and 2013 estimates on ROC due to continued weakness in the titanium dioxide business and the dissolution of the Talison...

Monness Crespi Hardt upgraded Huntsman (NYSE: HUN) from Sell to Neutral with an $18 price target. Monness Crespi Hardt noted, "The restructuring efforts that began last year seem to be taking hold, and Huntsman has been able to perform better than many of their competitors within several of their...

Monness Crespi Hardt raised its rating on Monsanto (NYSE: MON) from Neutral to Buy. Monness Crespi Hardt said, "We are upgrading Monsanto from Neutral to Buy as continually increasing glyphosate prices are leading to greater EPS upside in 2013. Average retail glyphosate prices have reached $15/...